“The latest expert source to attest to this impossibility used its experience in quantitative financial investment to analyze the progress being made by the 60 vaccine candidates. Boston-based PanAgora Asset Management analyzed vast quantities of medical research data to calculate which of the 60 will succeed in producing a successful vaccine within the year. The quick answer is “zero.”

View Here